Common Contracts

BioDelivery Sciences International, Inc. Placement Agency Agreement

Placement Agency Agreement • November 28th, 2012 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

• Contract Type
  Placement Agency Agreement
• Filed
  November 28th, 2012
• Company
  Biodelivery Sciences International Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell (i) an aggregate of 6,791,887 shares of common stock, par value $.001 per share, of the Company (“Common Stock”) and (ii) an aggregate of up to 2,709,300 shares of Series A Non-Voting Preferred Stock, par value $.001 per share, of the Company (the “Preferred Stock”) to certain investors (each an “Investor”), in an offering under its registration statement on Form S-3 (Registration No. 333-179257). The aggregate of up to 6,791,887 shares of Common Stock to be sold by the Company, the up to 2,709,300 shares of Preferred Stock to be sold by the Company and the shares of Common Stock issuable upon conversion of the Preferred Stock are herein collectively called the “Shares.” The Company desires to engage William Blair & Company, L.L.C. (“William Blair”), JMP Securities LLC (“JMP”) and Roth Capital Partners, LLC (“Roth”) in connecti

2,325,000 Shares SIERRA BANCORP Common Stock (no par value) Placement Agency Agreement

Placement Agency Agreement • October 14th, 2010 • Sierra Bancorp • State commercial banks • New York

• Contract Type
  Placement Agency Agreement
• Filed
  October 14th, 2010
• Company
  Sierra Bancorp
• Industry
  State commercial banks
• Jurisdiction
  New York

Sierra Bancorp, a California corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to issue and sell 2,325,000 shares (the “Shares”) of common stock, no par value (the “Common Stock”), directly to certain investors (collectively, the “Investors”). The Company desires to engage you as its placement agent (the “Placement Agent”) in connection with such issuance and sale of the Shares in a registered direct offering under the Registration Statement (as hereinafter defined). The Shares are more fully described in the Registration Statement.